A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone. The study will last approximately 47 weeks and may include about 15 visits.
Inclusion Criteria:
Exclusion Criteria:
Telangana, 500003, India
Chiyodaku, Tokyo 101 0041, Japan
Chuo-ku, Tokyo 103-0027, Japan
Chuo-ku, Tokyo 103-0028, Japan
Minato-ku, Tokyo 108 0075, Japan